GLP-1 Drugs Could Help Narrow Lifespan Gap in Serious Mental Illness

(MedPage Today) -- Starting a GLP-1 receptor agonist was associated with significantly lower risks of death and cardiovascular events in adults with serious mental illness (SMI), a target trial emulation showed. Among 195,184 propensity score...